1-9 of 9
Juliane S. Walz
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Trial in Progress: Phase I Trial Evaluating an Immunopeptidome-Defined Multi-Peptide Vaccine Against Acute Myeloid Leukemia Stem and Progenitor Cells

Susanne Jung, Annika Nelde, Yacine Maringer, Monika Denk, Lisa Zieschang, Christine Kammer, Melek Özbek, Christopher Hackenbruch, Jonas S. Heitmann, Helmut R. Salih, Juliane S. Walz
Journal: Blood
Blood (2024) 144 (Supplement 1): 1504.1.
https://doi.org/10.1182/blood-2024-198082
Published: 2024
Journal Articles

A Phase 1, Open-Label, Dose Escalation and Dose Expansion Study of Cln-049 for the Treatment of Acute Myeloid Leukemia Patients with Measurable Residual Disease

Jonas S. Heitmann, Juliane S. Walz, Helmut R. Salih, Klaus H Metzeler, Daniel Heudobler, Felicitas R Thol, Hermann Einsele, Veit L. Buecklein, Pau Montesinos, Ana Alfonso Pierola, Gala Vega, Eduardo Rodriguez Arboli, Juan Miguel Bergua Burgues, Suhail Chaudhry, Judith Inumerable, Todd Shearer, Laura Liu, Sandeep Kaur, Kaida Wu, Marion Subklewe
Journal: Blood
Blood (2024) 144 (Supplement 1): 2883.1.
https://doi.org/10.1182/blood-2024-201478
Published: 2024
Journal Articles

FLT3-ITD Driven CMTM6 Expression Contributes to Immune Escape of Acute Myeloid Leukemia

Melissa Zwick, Bastian Zinkel, Corinna Spohr, Tamina Rückert, Sebastian Halbach, Khalid Shoumariyeh, Lukas M. Braun, Annika Nelde, Melanie Maerklin, Samuel J. Holzmayer, Sandra Duquesne, Alexandra Emilia Schlaak, Patricia Otto-Mora, Bertram Bengsch, Marcel Schiff, Sandra Kissel, Marie Follo, Heidi Altmann, Désirée Kunadt, Anna Lena Illert, Juliane S. Walz, Gerd Walz, Justus Duyster, Johannes Schetelig, Tilman Brummer, Robert Zeiser, Natalie Koehler
Journal: Blood
Blood (2024) 144 (Supplement 1): 3392.
https://doi.org/10.1182/blood-2024-201449
Published: 2024
Journal Articles

First-in-Human Phase I Dose Escalation and Expansion Study Evaluating the Fc Optimized FLT3 Antibody Flysyn in Acute Myeloid Leukemia Patients with Minimal Residual Disease

Jonas S. Heitmann, MD, Daniela Dörfel, MD, Sabine Kayser, MD, Michael Heuser, Felicitas Thol, Silke Kapp-Schwoerer, MD, Wolfgang Bethge, MD, Ludger Grosse-Hovest, Martin Steiner, Melanie Märklin, PhD, Juliane S. Walz, MD, Richard F. Schlenk, Gundram Jung, MD, Helmut R. Salih
Journal: Blood
Blood (2020) 136 (Supplement 1): 8–9.
https://doi.org/10.1182/blood-2020-139493
Published: 2020
Journal Articles

Higher Dose of CPX-351 Is Associated with Prolonged Hematologic Recovery: Results from an Interim Safety Analysis of the Randomized, Phase III AMLSG 30-18 Trial

Verena I Gaidzik, MD, Verena Mayr-Benedikter, Daniela Weber, MSc, Anika Schrade, PhD, Jürgen Krauter, Juliane S. Walz, MD, Holger Hebart, MD, Beate S. Schultheis, MD, Nadezda Basara, MD, Elisabeth Dietl, MD, Silke Kapp-Schwoerer, MD, Michaela Feuring-Buske, MD, Felicitas Thol, Michael Heuser, Stefan Faderl, MD, Anthony J. Wagner, Maral Saadati, Julia Krzykalla, PhD, Axel Benner, Arnold Ganser, Konstanze Döhner, Peter Paschka, MD, Hartmut Döhner
Journal: Blood
Blood (2020) 136 (Supplement 1): 46–47.
https://doi.org/10.1182/blood-2020-138738
Published: 2020
Journal Articles

The HLA ligandome landscape of chronic myeloid leukemia delineates novel T-cell epitopes for immunotherapy

Tatjana Bilich, Annika Nelde, Leon Bichmann, Malte Roerden, Helmut R. Salih, Daniel J. Kowalewski, Heiko Schuster, Chih-Chiang Tsou, Ana Marcu, Marian C. Neidert, Maren Lübke, Jonas Rieth, Mirle Schemionek, Tim H. Brümmendorf, Vladan Vucinic, Dietger Niederwieser, Jens Bauer, Melanie Märklin, Janet K. Peper, Reinhild Klein, Oliver Kohlbacher, Lothar Kanz, Hans-Georg Rammensee, Stefan Stevanović, Juliane S. Walz
Journal: Blood
Blood (2019) 133 (6): 550–565.
https://doi.org/10.1182/blood-2018-07-866830
Published: 2019
Includes: Supplemental data
Journal Articles

Analysis of the Multiple Myeloma HLA Peptidome Identifies a Naturally Presented Bcma-Derived Peptide As an Immunogenic T-Cell Epitope for Immunotherapeutic Approaches

Tatjana Bilich, Simon D. Walz, Annika Nelde, Helmut R. Salih, MD, Ana Marcu, Daniel Johannes Kowalewski, Katja Weisel, MD, Lothar Kanz, Hans-Georg Rammensee, Stefan Stevanovic, Juliane S. Walz
Journal: Blood
Blood (2018) 132 (Supplement 1): 3173.
https://doi.org/10.1182/blood-2018-99-113473
Published: 2018
Journal Articles

Mass Spectrometry-Based Immunopeptidome Analysis of Acute Myeloid Leukemia Cells Under Decitabine Treatment Delineates Induced Presentation of Cancer/Testis Antigens on HLA Class I Molecules

Jens Bauer, Nora Zieger, Annika Nelde, Leon Bichmann, Helmut R. Salih, MD, Lothar Kanz, Hans-Georg Rammensee, Stefan Stevanovic, Juliane S. Walz
Journal: Blood
Blood (2018) 132 (Supplement 1): 5223.
https://doi.org/10.1182/blood-2018-99-113357
Published: 2018
Journal Articles

The HLA Ligandome Landscape of Chronic Myeloid Leukemia Delineates Novel T-Cell Epitopes for Immunotherapy

Tatjana Bilich, Annika Nelde, Leon Bichmann, Helmut R. Salih, MD, Daniel Johannes Kowalewski, Heiko Schuster, Ana Marcu, Marian C. Neidert, Maren Lübke, Jonas Rieth, Mirle Schemionek, Tim H Brümmendorf, MD, Vladan Vucinic, MD, Dietger Niederwieser, MD, Melanie Märklin, PhD, Janet K. Peper, Malte Roerden, Reinhild Klein, Oliver Kohlbacher, Lothar Kanz, Hans-Georg Rammensee, Stefan Stevanovic, Juliane S. Walz
Journal: Blood
Blood (2018) 132 (Supplement 1): 4243.
https://doi.org/10.1182/blood-2018-99-113376
Published: 2018